Daniel Schwarz

No open positions remaining

Finance

Consumer Services

Commercial Services

Profile

Daniel Schwarz worked as a Senior Auditor at KPMG from 2004 to 2007.
From 2018 to 2021, Mr. Schwarz was COO & CFO at Steelhead Capital Management LLC.
From 2018 to 2025, Mr. Schwarz was COO & CFO at BIOS Capital Management LP.
Mr. Schwarz graduated from Texas A&M University in 2003.

Former positions of Daniel Schwarz

Companies	Position	End
BIOS Capital Management LP BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements.	Director of Finance/CFO	2025-03-31
Steelhead Capital Management LLC Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager	Director of Finance/CFO	2021-05-31
KPMG KPMG Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax,investment advice and financial services	Comptroller/Controller/Auditor	2007-03-30

See the detail of Daniel Schwarz's experience

Training of Daniel Schwarz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Schwarz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Texas A&M University Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
KPMG KPMG Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax,investment advice and financial services	Commercial Services
Steelhead Capital Management LLC Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager	Finance
BIOS Capital Management LP BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements.	Finance